Patients with loss-of-function mutations in the PTEN gene, a negative regulator of mTOR signaling, are predisposed to developing macrocephaly, autism spectrum disorder (ASD), seizures, and intellectual disability [32]. This evidence concerns the gene PTEN and Macrocephaly.